Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial
Abstract Background Septic shock is characterized by an uncontrolled inflammatory response and microcirculatory dysfunction. There is currently no specific agent for treating septic shock. Anisodamine is an agent extracted from traditional Chinese medicine with potent anti-inflammatory effects. Howe...
Main Authors: | Yuetian Yu, Cheng Zhu, Yucai Hong, Lin Chen, Zhiping Huang, Jiancang Zhou, Xin Tian, Dadong Liu, Bo Ren, Cao Zhang, Caibao Hu, Xinan Wang, Rui Yin, Yuan Gao, Zhongheng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-021-03774-4 |
Similar Items
-
Effects and safety of different anisodamine doses on EVLW at early stage of septic shock patients
by: Ri-Xing Wang, et al.
Published: (2017-04-01) -
Beneficial effects of anisodamine in shock involved nicotinic anti-inflammatory pathway
by: Ting eZhao, et al.
Published: (2011-05-01) -
Effect of anisodamine injection-assisted azithromycin sequential therapy on serum indexes in children with mycoplasma pneumonia
by: Huan Zhang
Published: (2016-02-01) -
Use, timing and factors associated with tracheal intubation in septic shock: a prospective multicentric observational study
by: C. Darreau, et al.
Published: (2020-05-01) -
Protective effect of anisodamine in rats with glycerol-induced acute kidney injury
by: Yun-feng Li, et al.
Published: (2019-06-01)